Showing 1 - 3 of 3
Persistent link: https://www.econbiz.de/10001338003
Persistent link: https://www.econbiz.de/10011350656
The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper examines the incremental costs incurred for incremental health benefits gained from the largest available sample of cost-effectiveness studies of branded drugs in the USA, the...
Persistent link: https://www.econbiz.de/10013366987